Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomonas Infections 1Neutropenia 1Gram-Positive Bacterial Infections 1Fever 1

Interventions

pegfilgrastim 9Filgrastim 6eflapegrastim 3Docetaxel 3Cyclophosphamide 3posaconazole 1plerixafor 1isavuconazole 1ceftobiprole medocaril 1angiotensin I (1-7) 1Vancomycin 1Sodium Chloride 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Levofloxacin 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1EC regimen 1Daptomycin 1Cefepime 1Caspofungin 1Bevacizumab 1Algorithms 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neutropenia × ceftobiprole medocaril × Clear all
NCT00529282 2012-08-01

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Basilea Pharmaceutica

Phase 3 Terminated
2 enrolled 4 charts

Fever, Neutropenia, Pseudomonas Infections, Gram-Positive Bacterial Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡